Kempen Capital Management N.V. Bristol Myers Squibb CO Transaction History

Kempen Capital Management N.V.

$7.92 Billion
Q1 2024

A detailed history of Kempen Capital Management N.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kempen Capital Management N.V. holds 4,432 shares of BMY stock, worth $179,274. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,432

Previous 4,467 0.78%

Holding current value

$179,274

Previous $229,000 4.8%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $1,679 - $1,904	-35 Reduced 0.78%	4,432 $240,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $184,611 - $220,292	3,808 Added 577.85%	4,467 $229,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $3.07 Million - $3.41 Million	-48,239 Reduced 98.65%	659 $42,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $179,322 - $203,392	2,729 Added 5.91%	48,898 $3.39 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $22,735 - $26,921	332 Added 0.72%	46,169 $3.32 Million

Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $281 - $166,358	2,165 Added 4.96%	45,837 $3.26 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $120,040 - $132,206	1,653 Added 3.93%	43,672 $3.36 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $729,767 - $875,056	11,870 Added 39.37%	42,019 $3.07 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $88,006 - $102,595	-1,641 Reduced 5.16%	30,149 $1.88 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $75,796 - $88,786	1,281 Added 4.2%	31,790 $1.88 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $78,687 - $85,690	1,271 Added 4.35%	30,509 $2.04 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $235,639 - $265,024	3,971 Added 15.72%	29,238 $1.85 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $221,606 - $251,120	-3,838 Reduced 13.19%	25,267 $1.57 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $74,544 - $82,604	1,298 Added 4.67%	29,105 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $670,503 - $783,884	12,231 Added 78.52%	27,807 $1.64 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $13,734 - $19,959	-296 Reduced 1.86%	15,576 $868,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $743,120 - $969,333	15,101 Added 1958.63%	15,872 $1.02 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $34,787 - $41,479	771 New	771 $37,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.

Account

Kempen Capital Management N.V. Bristol Myers Squibb CO Transaction History